Target intelligence / Profile preview

Penicillin-binding proteins 3, 1A, 1B, 2 (PBP3, PBP1A, PBP1B, PBP2)

Target
PBP3, PBP1A, PBP1B, PBP2
Molecular classification
Enzyme (transpeptidase, transglycosylase activities depending on PBP), Bacterial membrane-associated macromolecule
01

Overview

Penicillin-binding proteins are critical bacterial enzymes involved in the late stages of peptidoglycan biosynthesis, which is essential for bacterial viability and maintenance of cell shape[1][3][6]. PBP1A and PBP1B (class A) are bifunctional enzymes with both transglycosylase and transpeptidase activities and contribute to the synthesis and integrity of the cell wall[5][3]. PBP2 and PBP3 (class B) primarily possess transpeptidase activity, with PBP2 involved in maintaining rod shape and PBP3 in septum formation and cell division[6][1]. β-lactam antibiotics target these proteins by mimicking their D-Ala-D-Ala substrate, resulting in covalent acylation of the active site serine residue and inhibition of enzymatic activity, leading to cell lysis. PBPs differ in their essentiality: for example, PBP3 is essential in *Pseudomonas aeruginosa* and *Escherichia coli*, while others are partially redundant[6][1][5]. Resistance to β-lactam drugs is frequently caused by mutations in PBPs that reduce antibiotic binding[6].

Other names
FtsIPonAMrcBPbpA
02

Mechanism of action

Irreversible covalent inhibition of transpeptidase or glycosyltransferase domains by β-lactam antibiotics, leading to loss of cell wall integrity and bacterial cell death

03

Biological functions

Peptidoglycan biosynthesisCell wall cross-linkingRegulation of cell shape, growth, and division
04

Disease associations

Infection (role in bacterial survival and virulence)
05

Safety considerations

Rapid resistance development due to PBP mutations or acquisition of alternative, low-affinity PBPsLimited penetration of some PBPs in Gram-negative species due to outer membrane permeability barriers
06

Interacting drugs

β-Lactam antibiotics (e.g., penicillins, cephalosporins, carbapenems, monobactams)

3 more in the full profile.

07

Biomarkers

Mutations in PBPs (especially PBP3 and PBP2) as markers of β-lactam resistance in pathogenic bacteriaPresence/overexpression of modified PBPs in resistant clinical isolates (e.g., MRSA, Pseudomonas)

Beyond the preview

Go deeper on Penicillin-binding proteins 3, 1A, 1B, 2 (PBP3, PBP1A, PBP1B, PBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding proteins 3, 1A, 1B, 2 (PBP3, PBP1A, PBP1B, PBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call